Cannabis Freedom Index
โ† All countriesCompare with other countries
๐Ÿ‡ง๐Ÿ‡ท

Brazil

South America

Restrictive

#32 of 196 worldwide
#5 of 12 in South America

Recreational: DecriminalisedMedical: Limited

In 2024 the Supreme Court decriminalised possession of up to 40 g or six female plants, now an administrative matter. Medical products are sold in pharmacies; policing remains uneven.

Score breakdown โ–world average

Select a segment to show or hide the exact rules and sources.

Possession ยท 25%3/10
adds 7.5 of 25 points

In June 2024 the Supreme Court ruled that possessing cannabis for personal use is not a crime, and set a presumption: up to 40 g counts as personal use. It is still prohibited โ€” the cannabis is seized and the person receives an administrative measure such as a warning or a mandatory educational course. Police can still treat someone under 40 g as a dealer if there is other evidence, such as scales or packaging.

Personal cultivation ยท 25%2/10
adds 5.0 of 25 points

The same ruling presumes that up to six female plants are for personal use, so growing them is an administrative infraction rather than a crime. It is not a right to grow: plants are seized. Some patients hold individual court orders allowing them to cultivate.

Punishment & enforcement ยท 20%3/10
adds 6.0 of 20 points

Users are no longer criminally punished, but Brazil's drug law is harsh on anyone classed as a dealer, and critics note that the line is drawn unevenly, falling hardest on poor and Black Brazilians.

Sharing & gifting ยท 10%1/10
adds 1.0 of 10 points
Consumption ยท 10%2/10
adds 2.0 of 10 points

Use remains an unlawful act subject to administrative measures, not criminal ones. Public use still leads to police stops and seizure.

Legal access ยท 10%1/10
adds 1.0 of 10 points

No adult-use sales. Pharmacies sell registered cannabis products on prescription, and patients can import with authorisation from the health regulator.

More context not part of the score

Commercial production

In February 2026 the health regulator published rules allowing companies to cultivate low-THC cannabis (0.3% or less) for medical, pharmaceutical and research purposes under special authorisation, after a 2024 high-court order. The cultivation rules took effect on 4 August 2026, and patient associations may grow for their members in a supervised trial scheme. No adult-use production.

Products

Prescription oils and extracts, mostly CBD-dominant; no legal flower for general sale.

Medical use

Doctors can prescribe registered or imported cannabis products; costs are high, and patient associations and court-authorised home growers fill part of the gap.

Other consequences

Administrative measures do not create a criminal record. The ruling opened the way to review past convictions for small amounts.

All sources

  1. Conectas โ€” Brazilian Supreme Court decriminalizes possession of marijuana for personal use
  2. Global Voices โ€” What changes will arise from the Supreme Court's ruling on personal marijuana use
  3. Sechat โ€” STF establishes 40 g or 6 female plants for personal use
  4. GrowerIQ โ€” Brazil's ANVISA publishes five new cannabis resolutions (2026)

Last updated: